General Information of Drug (ID: DM5QAKR)

Drug Name
Hydroxyqunoline analog 5 Drug Info
Synonyms PMID25468267-Compound-45
Cross-matching ID
PubChem CID
70679266
TTD Drug ID
DM5QAKR

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID25468267-Compound-46 DMSKCEH N. A. N. A. Patented [1]
Hydroxyqunoline analog 1 DMAJFDT N. A. N. A. Patented [1]
N-oxalyl-D-tyrosine derivative 2 DMWSZMC N. A. N. A. Patented [1]
Hydroxyqunoline analog 2 DMX3TZ7 N. A. N. A. Patented [1]
N-oxalyl-D-tyrosine derivative 7 DM13K8R N. A. N. A. Patented [1]
Pyridine-2,4-dicarboxylic acid analog 4 DMGPCSR N. A. N. A. Patented [1]
N-oxalyl-D-tyrosine derivative 9 DMTMYJ6 N. A. N. A. Patented [1]
Pyridine-2,4-dicarboxylic acid analog 2 DMCNWPI N. A. N. A. Patented [1]
N-oxalyl-D-tyrosine derivative 5 DM673GR N. A. N. A. Patented [1]
N-oxalyl-D-tyrosine derivative 4 DMUE7R5 N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lysine-specific demethylase 4E (KDM4E) TTWAQBO KDM4E_HUMAN Inhibitor [1]

References

1 KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44.